文献速递妇科

前哨淋巴结算法与全面淋巴结清扫在浆液性和透明细胞子宫内膜癌中的肿瘤学结局比较:多中心研究

Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
PubMed 文献 · Gynecol Oncol · 2019-11-24

该多中心研究比较了前哨淋巴结(SLN)算法与全面盆腔及腹主动脉旁淋巴结清扫(LND)在浆液性或透明细胞子宫内膜癌中的生存结局。共纳入214例患者(SLN组118例,LND组96例),经逆概率治疗加权调整后,SLN组3年无复发生存率(RFS)为69%,LND组为80%;3年总生存率(OS)分别为88%和77%。在168例淋巴结阴性患者中,SLN组3年RFS为73%,LND组为91%,但OS相似。结论认为SLN算法未损害OS,但可能与淋巴结阴性病例RFS降低相关。

要点

  • SLN算法与全面LND相比,调整后3年OS分别为88%和77%,SLN未损害总生存。
  • 淋巴结阴性亚组中,SLN组3年RFS为73%,低于LND组的91%,HR为3.12(95%CI 1.02-9.57)。
  • SLN组和LND组分别有84%和40%接受化疗±放疗,辅助治疗存在差异。

核心结论

  • SLN算法未损害总生存;在淋巴结阴性病例中,SLN可能与RFS降低相关但OS相似,尽管多数接受了化疗,这可能源于监测差异。

研究设计与样本

  • 多中心研究,比较一个使用全面LND至肾静脉的机构与另一个使用SLN算法加超分期的机构,共纳入214例浆液性或透明细胞子宫内膜癌患者(SLN组118例,LND组96例),采用倾向评分逆概率治疗加权调整协变量不平衡。

主要发现

  • SLN组和LND组分别有84%和40%接受化疗±放疗。
  • IPTW调整后3年RFS率SLN组为69%,LND组为80%;3年OS率SLN组为88%,LND组为77%。
  • IPTW调整后手术方式(SLN vs LND)与进展和死亡的HR分别为1.46(95%CI 0.70-3.04)和0.44(95%CI 0.19-1.02)。
  • 在168例淋巴结阴性病例中,IPTW调整后3年RFS率SLN组为73%,LND组为91%;3年OS率SLN组为88%,LND组为86%。
  • 淋巴结阴性亚组中,IPTW调整后手术方式与进展和死亡的HR分别为3.12(95%CI 1.02-9.57)和0.69(95%CI 0.24-1.95)。

临床怎么用

  • 原文结论认为SLN算法未损害OS,但淋巴结阴性病例中SLN可能与RFS降低相关,作者指出这可能源于监测差异,未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare survival after nodal assessment using a sentinel lymph node (SLN) algorithm versus comprehensive pelvic and paraaortic lymphadenectomy (LND) in serous or clear cell endometrial carcinoma, and to compare survival in node-negative cases. METHODS: Three-year recurrence-free survival (RFS) and overall survival were compared between one institution that used comprehensive LND to the renal veins and a second institution that used an SLN algorithm with ultra-staging with inverse-probability of treatment weighting (IPTW) derived from propensity scores to adjust for covariate imbalance between cohorts. RESULTS: 214 patients were identified (118 SLN cohort, 96 LND cohort). Adjuvant therapy differed between the cohorts; 84% and 40% in the SLN and LND cohorts, respectively, received chemotherapy ± radiation therapy. The IPTW-adjusted 3-year RFS rates were 69% and 80%, respectively. The IPTW-adjusted 3-year OS rates were 88% and 77%, respectively. The IPTW-adjusted hazard ratio (HR) for the association of surgical approach (SLN vs LND) with progression and death was 1.46 (95% CI: 0.70-3.04) and 0.44 (95% CI: 0.19-1.02), respectively. In the 168 node-negative cases, the IPTW-adjusted 3-year RFS rates were 73% and 91%, respectively. The IPTW-adjusted 3-year OS rates were 88% and 86%, respectively. In this subgroup, IPTW-adjusted HR for the association of surgical approach (SLN vs LND) with progression and death was 3.12 (95% CI: 1.02-9.57) and 0.69 (95% CI: 0.24-1.95), respectively. CONCLUSION: OS was not compromised with the SLN algorithm. SLN may be associated with a decreased RFS but similar OS in node-negative cases despite the majority receiving chemotherapy. This may be due to differences in surveillance.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Schlappe BA, Weaver AL, McGree ME, et al. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. Gynecol Oncol. 2019. PMID: 31776037. doi:10.1016/j.ygyno.2019.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。